H3K27me3 methyltransferase and demethylase inhibitors (UNC1999 and GSKJ4) as well as a PRMT5 inhibitor (GSK591) also had antiproliferative effects on a wide variety of cancer cells, including TNBC7,19,20. This evidence concerns the gene PRMT5 and cancer.